Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative, Controlled Clinical Investigation of a New Acoustic Feedback Cancellation Strategy in Comparison With the Currently Marketed System

NCT04146272 is registered in ClinicalTrials.gov with Bernafon AG as lead sponsor.

NCT NCT04146272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04146272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative, Controlled Clinical Investigation of a New Acoustic Feedback Cancellation Strategy in Comparison With the Currently Marketed System
Lead sponsor
Bernafon AG
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
July 7, 2019
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss